Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI).
Tamura T, Numata T, Yanai H, Nakamura R, Shiozawa T, Watanabe H, Okauchi S, Kikuchi N, Miyazaki K, Hayashi S, Yamashita T, Kurishima K, Inagaki M, Satoh H, Ishikawa H, Kaburagi T, Endo T, Sakamoto T, Hizawa N.
Tamura T, et al. Among authors: watanabe h.
Anticancer Res. 2023 Oct;43(10):4583-4591. doi: 10.21873/anticanres.16652.
Anticancer Res. 2023.
PMID: 37772562